Now showing items 1-1 of 1
The immunological dilemma: Cellular innate and adaptive immune response versus human acute myeloid leukemia
(Bentham Science Publishers Ltd., 2007)
It is generally accepted that acute myelogenous leukemia (AML) patients are immunocompromized. On the other hand, antileukemic immune reactivity is important for the improved survival of AML patients treated with ...